Necrotising enterocolitis · very preterm or very low birth weight infants
Slow showed no clear difference in necrotising enterocolitis before hospital discharge compared with faster rates of enteral feed advancement (moderate certainty).
1 finding from 1 review
Mortality before hospital discharge · very preterm or very low birth weight infants
Slow showed no clear difference in mortality before hospital discharge compared with faster rates of enteral feed advancement (moderate certainty).
1 finding from 1 review
Feed intolerance · very preterm or very low birth weight infants
Slow may leads to higher feed intolerance before hospital discharge compared with faster rates of enteral feed advancement (low certainty).
1 finding from 1 review
Invasive infection (before hospital discharge) · very preterm or very low birth weight infants
Slow showed no clear difference in invasive infection before hospital discharge compared with faster rates of enteral feed advancement (low certainty).
1 finding from 1 review
Adverse effects: pain on injection (solution deposition), Heft-Parker VAS 0-170 mm · patients treated with subcutaneous heparin injections
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · patients treated with subcutaneous heparin injections
1 finding from 1 review
Bruise size 48 hours after injection (mm/mm2) · patients treated with subcutaneous heparin injections
1 finding from 1 review
Bruise size ‐ 60 hours after injection (mm2) · patients treated with subcutaneous heparin injections
1 finding from 1 review
Bruise size ‐ 72 hours after injection (mm2) · patients treated with subcutaneous heparin injections
1 finding from 1 review
Bruise incidence ‐ 48 hours after injection · patients treated with subcutaneous heparin injections
Slow may leads to lower bruise incidence ‐ 48 hours after injection compared with fast subcutaneous heparin injection (low certainty).
2 findings from 1 review
Retention of slow-release fluoride devices (devices staying intact) · Children with high risk of dental decay
1 finding from 1 review
Harms of slow-release fluoride devices · Children with high risk of dental decay
1 finding from 1 review
Stability of crossbite correction (relapse of canine expansion) · Children and adults with a posterior crossbite, without a Class III skeletal relationship, cleft lip or palate (or both), or other…
1 finding from 1 review
Canine expansion · Children and adults with a posterior crossbite, without a Class III skeletal relationship, cleft lip or palate (or both), or other…
1 finding from 1 review
Stability of crossbite correction (relapse of molar expansion) · Children and adults with a posterior crossbite, without a Class III skeletal relationship, cleft lip or palate (or both), or other…
1 finding from 1 review
Molar expansion · Children and adults with a posterior crossbite, without a Class III skeletal relationship, cleft lip or palate (or both), or other…
1 finding from 1 review
Slow-release fluoride devices vs Alternative fluoride therapy (topical fluoride: toothpaste, mouthrinse, gel, or varnish)
Outcome not reported · Children or adults
The review found no eligible studies for this question.
1 finding from 1 review
Caries increment, surface index D(M)FS · Children with high risk of dental decay
It is very uncertain whether slow-release fluoride device (fluoride glass beads) changes increase in DMFS at 2 years compared with baseline compared with placebo or usual care (control) (very low certainty).
1 finding from 1 review
Caries increment, tooth index D(M)FT · Children with high risk of dental decay
It is very uncertain whether slow-release fluoride device (fluoride glass beads) changes increase in DMFT at 2 years compared with baseline compared with placebo or usual care (control) (very low certainty).
1 finding from 1 review
Progression of caries lesion into enamel or dentine · Children with high risk of dental decay
The review found no eligible studies for this question.
1 finding from 1 review
No evidence found
0 studies
No studies found